Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.

"Competing interests: DAB has received travel/congress support from EISAI, Lilly, Bristol-Myers Squibb, MSD; honoraria for consulting or advisory boards from Roche, EISAI, MSD; honoraria for lectures from Ipsen unrelated to the submitted work. FM received has received honoraria for advisory boards from Servier and Bristol-Myers Squibb. LK has received honoraria for travel/congress support and consulting/advisory roles from Bristol Myers Squibb (BMS), Merck Sharp & Dome (MSD), Novartis, Pierre Fabre and Sanofi Aventis unrelated to the submitted work. ER stated the following conflicts of interest: Honoraria: Amgen, BMS, Delcath, MSD, Merck, Novartis, Pierre Fabre, Sanofi. Consulting or advisory role: Amgen, BMS, MSD, Merck, Novartis, Pierre Fabre, Sanofi. Speakers’ bureau: Amgen, BMS, MSD, Merck, Novartis, Pierre Fabre, Sanofi. Former Site PI for Medical University of Graz (last three years): Amgen, BMS, Curevac, Incyte, MSD, Merck, Novartis, Pierre Fabre, Roche. To date Site PI for Medical University of Graz: Delcath. Steering Committee: Novartis. Travel reimbursements: Amgen, BMS, MSD, Merck, Novartis, Pierre Fabre, Sanofi. Stock (under US$10,000): Roche. Honorary member of the Austrian Cancer Aid and the Austrian Cancer Aid/StyriaMP (Matthias Preusser) has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, Gan & Lee Pharmaceuticals, Servier. MP declares no conflict of interest related to this work. JMR has received honoraria for lectures from BMS and MSD."

"Funding: This research was supported by a research grant from AstraZeneca GmbH,Bristol-Myers Squibb GesmbH (BMS), Merck Sharp & Dohme Ges.m.b.H., Roche Austria and Sanofi-aventis. The hypothesis of this study was not suggested by the the funding body, which had no role in the design, analysis, and publication of this study. MP gratefully acknowledges financial support from the Austrian Federal Ministry for Digital and Economic Affairs, the Austrian National Foundation for Research, Technology and Development and the Christian Doppler Research Association."